ADNYX | PMAQX | ADNYX / PMAQX | |
Total Expense Ratio | 1.09 | 0.59 | 185% |
Annual Report Gross Expense Ratio | 1.17 | 0.59 | 198% |
Fund Existence | 8 years | 9 years | - |
Gain YTD | 9.806 | 2.039 | 481% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 183M | 30.6B | 1% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | 41.24 | 10.62 | 388% |
Returns for 3 years | 55.01 | 50.92 | 108% |
Returns for 5 years | -27.48 | 56.82 | -48% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
JAAA | 50.65 | -0.01 | -0.02% |
Janus Henderson AAA CLO ETF | |||
GHYG | 45.45 | -0.15 | -0.32% |
iShares US & Intl High Yield Corp Bd ETF | |||
BNDW | 68.77 | -0.23 | -0.33% |
Vanguard Total World Bond ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors |